Final answer:
Clozapine, olanzapine, and quetiapine are atypical antipsychotics that have been associated with cardiac and metabolic issues.
Step-by-step explanation:
When it comes to atypical antipsychotics, some medications have a higher risk of causing cardiac and metabolic issues compared to others. One such medication is clozapine. It is known for its potential to cause weight gain, metabolic syndrome, and a condition called agranulocytosis. Agranulocytosis is a severe reduction in white blood cell count, which can lead to serious infections.
Another atypical antipsychotic that has been associated with cardiac and metabolic issues is olanzapine. It is known to cause weight gain, insulin resistance, dyslipidemia, and an increased risk of developing diabetes.
One more atypical antipsychotic that can have adverse effects on cardiac and metabolic health is quetiapine. It has been linked to weight gain, dyslipidemia, and an increased risk of developing diabetes.